Comment
doi: 10.1016/S0140-6736(07)61170-2.
Interferon beta in multiple sclerosis: how much BENEFIT?
Affiliations
- PMID: 17678997
- DOI: 10.1016/S0140-6736(07)61170-2
Item in Clipboard
Comment
Interferon beta in multiple sclerosis: how much BENEFIT?
Lancet.
.
Erratum in
- Lancet. 2007 Oct 6;370(9594):1208
No abstract available
Comment on
-
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study.Lancet. 2007 Aug 4;370(9585):389-97. doi: 10.1016/S0140-6736(07)61194-5. Lancet. 2007. PMID: 17679016 Clinical Trial.
Similar articles
-
Interferon beta-1b (Extavia) for multiple sclerosis.Med Lett Drugs Ther. 2010 Nov 1;52(1350):86-7. Med Lett Drugs Ther. 2010. PMID: 21045760 No abstract available.
-
Interferon-beta for multiple sclerosis: Long-term benefits?Ann Neurol. 2007 Apr;61(4):283-5. doi: 10.1002/ana.21119. Ann Neurol. 2007. PMID: 17444503 No abstract available.
-
Use of interferon-beta in the treatment of multiple sclerosis.Adv Neurol. 2006;98:257-71. Adv Neurol. 2006. PMID: 16400838 Review. No abstract available.
-
[Logistics and description of treatment technology (the protocol for using disease modifying drugs--DMD)].Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(2 Pt 2):93-8. Zh Nevrol Psikhiatr Im S S Korsakova. 2011. PMID: 21916163 Russian. No abstract available.
-
[Beta interferon and multiple sclerosis].Duodecim. 1996;112(24):2368-73. Duodecim. 1996. PMID: 10605237 Review. Finnish. No abstract available.
Cited by
-
Interferon beta and glatiramer acetate therapy.Neurotherapeutics. 2013 Jan;10(1):2-18. doi: 10.1007/s13311-012-0163-4. Neurotherapeutics. 2013. PMID: 23264098 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
